ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
Dow Jones
40.954,48
1,85%
Euro vs US Dollar
1,09002
0,01%
Bitcoin
64.665,00
-0,29%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTH)

  7. Arch Therapeutics Inc (QB) (ARTH) News

ARTH

Arch Therapeutics (QB) (ARTH)

Arch Therapeutics Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:ARTH
DatumZeitQuelleÜberschriftSymbolFirma
06/08/201413h36Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
08/07/201417h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
08/07/201417h57Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ARTHArch Therapeutics Inc (QB)
08/07/201412h00Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
07/07/201423h31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
03/07/201412h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
03/07/201412h01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
27/06/201420h17Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
19/06/201422h12Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
16/06/201414h15MarketwiredArch Therapeutics Co-Founder Rutledge Ellis-Behnke to Speak at European Summit for Clinical Nanomedicine & Targeted Medicine ...USOTC:ARTHArch Therapeutics Inc (QB)
28/05/201415h00MarketwiredArch Therapeutics Inc. to Present at the LD MICRO Invitational 2014 on June 4thUSOTC:ARTHArch Therapeutics Inc (QB)
27/05/201415h00MarketwiredArch Therapeutics Inc. to Present at the Third Annual Marcum MicroCap ConferenceUSOTC:ARTHArch Therapeutics Inc (QB)
15/05/201421h48Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
05/05/201414h41Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
01/04/201414h00MarketwiredArch Therapeutics Appoints Chirag Shah, PhD as Vice President of R&D Engineering & Quality Systems & Peter LaCrosse as Chief ...USOTC:ARTHArch Therapeutics Inc (QB)
27/03/201421h25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
26/03/201414h00MarketwiredArch Therapeutics Co-Founder Rutledge Ellis-Behnke, PhD Presents at Two Scientific Meetings in MarchUSOTC:ARTHArch Therapeutics Inc (QB)
25/03/201420h57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
25/03/201420h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
25/03/201420h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
25/03/201420h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
21/03/201422h20Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARTHArch Therapeutics Inc (QB)
26/02/201415h00MarketwiredArch Therapeutics to Present at The Wall Street Analyst Forum Institutional Investor ConferenceUSOTC:ARTHArch Therapeutics Inc (QB)
14/02/201414h40Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
10/02/201415h00MarketwiredArch Therapeutics Secures $2.85 Million Private PlacementUSOTC:ARTHArch Therapeutics Inc (QB)
10/02/201412h06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
07/02/201415h11Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ARTHArch Therapeutics Inc (QB)
31/01/201412h08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
31/01/201412h00MarketwiredArch Therapeutics Announces $2.85 Million Private PlacementUSOTC:ARTHArch Therapeutics Inc (QB)
22/01/201417h00MarketwiredArch Therapeutics Presents 2014 Milestones During Live WebcastUSOTC:ARTHArch Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:ARTH

Kürzlich von Ihnen besucht

NYSE
JPM
JP Morgan Chase
NASDAQ
NVDA
NVIDIA
TG
NOV
Novo Nordisk
NASDAQ
AMZN
Amazon.com
PM
XAUUSD
Gold vs US Dollar
DBI
MDAX
MDAX
CCOM
US500
US 500
CCOM
US30
US 30
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
NYSE
XOM
Exxon Mobil
NASDAQ
AAPL
Apple
NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten